PROVIDER PROFILE · NPI 1811090053
Julie Gayle
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
62
Beneficiaries
—
Total drug cost
$152K
Distinct drugs
2
Brand share
100.0%
Top prescribed drugs
Emtricitabine/Tenofov Alafenam51 claims
Cabotegravir11 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$14
Payment records
1
By payment type
Food and Beverage$14
Top paying entities
Food and Beverage$14
CROSS-REFERENCE